Background A 63-year-old man with a 4-year history of Wegener's granulomatosis presented with hemoptysis, palatal ulceration and sensorimotor polyneuropathy.
Investigations Physical examination, serologic testing, proteinase 3 enzyme-linked immunosorbent assay, IgG and IgM specific to Epstein–Barr virus enzyme-linked immunosorbent assay, MRI of the middle face, an ear, nose and throat consultation, immunohistochemical staining of an esophageal sample obtained from esophagogastroduodenoscopy, polymerase chain reaction of cytomegalovirus (CMV) DNA from esophageal and blood samples, and measurement of pp65 early antigen.
Diagnosis Wegener's granulomatosis with progressive palatal ulceration and osseous destruction complicated by CMV-related esophagitis during induction treatment.
Management Induction treatment with cyclophosphamide pulse therapy was discontinued and antiviral therapy with ganciclovir was started. Cyclophosphamide pulse therapy was later reintroduced, but there was subsequent CMV reactivation, and, therefore, cyclophosphamide pulse therapy was suspended again and ganciclovir and intravenous immunoglobulin were started. After control of CMV, cyclophosphamide pulse therapy was reinitiated. Prolonged immunosuppressive therapy controlled disease activity, without CMV reactivation.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Leavitt RY et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33: 1101–1107
Jennette JC et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187–192
Jayne D (2001) Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol 13: 48–55
Rasmussen N (2001) Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective. Curr Opin Rheumatol 13: 3–11
Knecht K and Mishriki YY (1999) More than a mouth ulcer. Oral ulcer due to Wegener's granulomatosis. Postgrad Med 105: 200–203
Torres HA et al. (2005) Gastrointestinal cytomegalivirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer 41: 2268–2279
Bottomley WW et al. (1992) Esophageal involvement in Behcet's disease. Is endoscopy necessary? Dig Dis Sci 37: 594–597
Fauci AS et al. (1983) Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98: 76–85
de Groot K and Jayne D (2005) What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides. Clin Nephrol 64: 480–484
Aries PM et al. (2005) Intravenous immunoglobulin therapy in vasculitis: speculation or evidence? Clin Rev Allergy Immunol 29: 237–245
Aries PM et al. (2006) Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations. Ann Rheum Dis 65: 853–858
Centers for Disease Control and Prevention; Infectious Disease Society of America; American Society of Blood and Marrow Transplantation (2000) Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 6: 659–713; 715; 717–727
Hodson EM et al. (2005) Antiviral medications to prevent cytomegalovirus disease and early death in reciepiens of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 365: 2105–2115
Markham A and Faulds D (1994) Ganciclovir. An update of its therapeutic use in cytomegalovirus infection. Drugs 48: 455–484
Blanshard C et al. (1995) Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison. J Infect Dis 172: 622–628
Whitley RJ et al. (1998) Guidelines for the treatment of cytomegalovirus disease in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med 158: 957–969
Blanshard C (1992) Treatment of HIV-related cytomegalovirus disease of the gastrointestinal tract with foscarnet. J Acquir Immune Defic Syndr 5 (Suppl 1): S25–S28
Jacobson MA (2006) AIDS-related cytomegalovirus gastrointestinal disease. [www.uptodate.com] (accessed 30 June 2006)
The authors declare no competing financial interests.
About this article
Cite this article
Aries, P., Ullrich, S. & Gross, W. A case of destructive Wegener's granulomatosis complicated by cytomegalovirus infection. Nat Rev Rheumatol 2, 511–515 (2006). https://doi.org/10.1038/ncprheum0269
Colonic perforation due to severe cytomegalovirus disease in granulomatosis with polyangiitis after immunosuppression
Clinical Rheumatology (2018)
Cytomegalovirus disease of the upper gastrointestinal tract in patients with rheumatic diseases: a case series and literature review
Clinical Rheumatology (2013)
Oral and Maxillofacial Surgery (2012)